A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cancer Research UK
Massachusetts General Hospital
Augusta University
Abramson Cancer Center at Penn Medicine